Status (A) and duration (B) of breast feeding among participants. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the knowledge scores. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the attitude scores. by Sara Saleh (6733619)

Subjects:

Multivariate analysis of sociodemographic and other factors associated with the KAP scores. by Sara Saleh (6733619)

Subjects:

Participants’ perceived ways to boost children’s immune system other than vaccination. by Sara Saleh (6733619)

Subjects:

Bivariate analysis of sociodemographic and other factors associated with the practice scores. by Sara Saleh (6733619)

Subjects:

Impact on different areas of health. by Margherita Molaro (17803989)

Subjects:

Demographic information of participants. by Zixia Bu (21475019)

Subjects:

Correlation results between PA and different table variables. by Zixia Bu (21475019)

Subjects:

Correlation heatmap between physical activity and individual variables. by Zixia Bu (21475019)

Subjects:

Cross-lagged panel model based on physical activity, aggressive behavior and Chinese language learning. by Zixia Bu (21475019)

Subjects:

Cross-lagged panel model consistency test based on physical activity, aggressive behavior and Chinese language learning. by Zixia Bu (21475019)

Subjects:

Comparison of the fit of multiple cluster analyses of the cross-lagged panel model. by Zixia Bu (21475019)

Subjects:

PA inhibits PI3K/AKT pathways in osteosarcoma cells. by Zeyu Zhan (22305085)

Subjects:

PA-induced apoptosis in osteosarcoma cells. by Zeyu Zhan (22305085)

Subjects:

Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

Subjects:

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects: